
Kauvery Hospital launches CAR-T cell therapy for blood cancers
It is designed to treat lymphoblastic leukaemia and diffuse large B-cell lymphoma.
India’s Kauvery Hospital has announced the launch of its CAR-T cell therapy service for certain blood cancers that do not respond to conventional treatments.
Immune cells known as “T-cells” are collected from the patient, and then modified to recognise and attack cancer cells before being infused back into the body.
The treatment is primarily offered for patients with lymphoblastic leukaemia and diffuse large B-cell lymphoma.